These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 19359282)

  • 1. The maximum standardized uptake values on positron emission tomography to predict the Noguchi classification and invasiveness in clinical stage IA adenocarcinoma measuring 2 cm or less in size.
    Maeda R; Isowa N; Onuma H; Miura H; Harada T; Touge H; Tokuyasu H; Kawasaki Y
    Interact Cardiovasc Thorac Surg; 2009 Jul; 9(1):70-3. PubMed ID: 19359282
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The maximum standardized 18F-fluorodeoxyglucose uptake on positron emission tomography predicts lymph node metastasis and invasiveness in clinical stage IA non-small cell lung cancer.
    Maeda R; Isowa N; Onuma H; Miura H; Harada T; Touge H; Tokuyasu H; Kawasaki Y
    Interact Cardiovasc Thorac Surg; 2009 Jul; 9(1):79-82. PubMed ID: 19366724
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prediction of pathologic node-negative clinical stage IA lung adenocarcinoma for optimal candidates undergoing sublobar resection.
    Tsutani Y; Miyata Y; Nakayama H; Okumura S; Adachi S; Yoshimura M; Okada M
    J Thorac Cardiovasc Surg; 2012 Dec; 144(6):1365-71. PubMed ID: 22883546
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic value of preoperative FDG-PET in stage IA lung adenocarcinoma.
    Murakami S; Saito H; Sakuma Y; Kondo T; Oshita F; Ito H; Tsuboi M; Hasegawa C; Yokose T; Kameda Y; Nakayama H; Yamada K
    Eur J Radiol; 2012 Aug; 81(8):1891-5. PubMed ID: 21546177
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk Factors for Predicting Occult Lymph Node Metastasis in Patients with Clinical Stage I Non-small Cell Lung Cancer Staged by Integrated Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography.
    Kaseda K; Asakura K; Kazama A; Ozawa Y
    World J Surg; 2016 Dec; 40(12):2976-2983. PubMed ID: 27456499
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumour standardized uptake value on positron emission tomography is a novel predictor of adenocarcinoma in situ for c-Stage IA lung cancer patients with a part-solid nodule on thin-section computed tomography scan.
    Hattori A; Suzuki K; Matsunaga T; Fukui M; Tsushima Y; Takamochi K; Oh S
    Interact Cardiovasc Thorac Surg; 2014 Mar; 18(3):329-34. PubMed ID: 24351509
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preoperative 18F-fluorodeoxyglucose positron emission tomography can predict the tumor malignancy of small peripheral lung cancer.
    Kosaka T; Yamaki E; Tanaka S; Mogi A; Kuwano H
    Ann Thorac Cardiovasc Surg; 2014; 20(6):968-73. PubMed ID: 24284507
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oncologic outcomes of segmentectomy compared with lobectomy for clinical stage IA lung adenocarcinoma: propensity score-matched analysis in a multicenter study.
    Tsutani Y; Miyata Y; Nakayama H; Okumura S; Adachi S; Yoshimura M; Okada M
    J Thorac Cardiovasc Surg; 2013 Aug; 146(2):358-64. PubMed ID: 23477694
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The significance of maximum standardized uptake values in patients with stage I pulmonary adenocarcinoma.
    Kim HR; Kim DJ; Lee WW; Jheon S; Sung SW
    Eur J Cardiothorac Surg; 2009 Apr; 35(4):712-6; discussion 716-7. PubMed ID: 19211260
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multivariate analysis based on the maximum standard unit value of
    Wang Y; Lyu D; Zhou T; Tu W; Fan L; Liu S
    Diagn Interv Radiol; 2023 Mar; 29(2):379-389. PubMed ID: 36988049
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Solid tumor size on high-resolution computed tomography and maximum standardized uptake on positron emission tomography for new clinical T descriptors with T1 lung adenocarcinoma.
    Tsutani Y; Miyata Y; Nakayama H; Okumura S; Adachi S; Yoshimura M; Okada M
    Ann Oncol; 2013 Sep; 24(9):2376-81. PubMed ID: 23788749
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multicenter analysis of high-resolution computed tomography and positron emission tomography/computed tomography findings to choose therapeutic strategies for clinical stage IA lung adenocarcinoma.
    Okada M; Nakayama H; Okumura S; Daisaki H; Adachi S; Yoshimura M; Miyata Y
    J Thorac Cardiovasc Surg; 2011 Jun; 141(6):1384-91. PubMed ID: 21440264
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 18F-fluorodeoxyglucose positron emission tomographic scan in solid-type p-stage-I pulmonary adenocarcinomas: what can produce false-negative results?
    Lococo F; Galeone C; Formisano D; Bellafiore S; Filice A; Annunziata T; Cesario A; Rapicetta C; Fioroni F; Ricchetti T; Paci M
    Eur J Cardiothorac Surg; 2017 Apr; 51(4):667-673. PubMed ID: 28043987
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [F-18]Fluorodeoxyglucose positron emission tomography can predict pathological tumor stage and proliferative activity determined by Ki-67 in clinical stage IA lung adenocarcinomas.
    Watanabe K; Nomori H; Ohtsuka T; Naruke T; Ebihara A; Orikasa H; Yamazaki K; Uno K; Kobayashi T; Goya T
    Jpn J Clin Oncol; 2006 Jul; 36(7):403-9. PubMed ID: 16782729
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fluorine 18-tagged fluorodeoxyglucose positron emission tomographic scanning to predict lymph node metastasis, invasiveness, or both, in clinical T1 N0 M0 lung adenocarcinoma.
    Nomori H; Watanabe K; Ohtsuka T; Naruke T; Suemasu K; Kobayashi T; Uno K
    J Thorac Cardiovasc Surg; 2004 Sep; 128(3):396-401. PubMed ID: 15354098
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic impact of the integration of volumetric quantification of the solid part of the tumor on 3DCT and FDG-PET imaging in clinical stage IA adenocarcinoma of the lung.
    Furumoto H; Shimada Y; Imai K; Maehara S; Maeda J; Hagiwara M; Okano T; Masuno R; Kakihana M; Kajiwara N; Ohira T; Ikeda N
    Lung Cancer; 2018 Jul; 121():91-96. PubMed ID: 29858033
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic impact of FDG-PET in surgically treated pathological stage I lung adenocarcinoma.
    Higuchi M; Hasegawa T; Osugi J; Suzuki H; Gotoh M
    Ann Thorac Cardiovasc Surg; 2014; 20(3):185-91. PubMed ID: 23603641
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Associations among bronchioloalveolar carcinoma components, positron emission tomographic and computed tomographic findings, and malignant behavior in small lung adenocarcinomas.
    Okada M; Tauchi S; Iwanaga K; Mimura T; Kitamura Y; Watanabe H; Adachi S; Sakuma T; Ohbayashi C
    J Thorac Cardiovasc Surg; 2007 Jun; 133(6):1448-54. PubMed ID: 17532938
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic significance of using solid versus whole tumor size on high-resolution computed tomography for predicting pathologic malignant grade of tumors in clinical stage IA lung adenocarcinoma: a multicenter study.
    Tsutani Y; Miyata Y; Nakayama H; Okumura S; Adachi S; Yoshimura M; Okada M
    J Thorac Cardiovasc Surg; 2012 Mar; 143(3):607-12. PubMed ID: 22104678
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Correlation of 18F-fluorodeoxyglucose uptake on positron emission tomography with Ki-67 index and pathological invasive area in lung adenocarcinomas 30 mm or less in size.
    Murakami S; Saito H; Sakuma Y; Mizutani Y; Ishikawa Y; Kondou T; Oshita F; Yokose T; Kameda Y; Suga Y; Ito H; Tsuboi M; Nakayama H; Noda K; Yamada K
    Eur J Radiol; 2010 Aug; 75(2):e62-6. PubMed ID: 20005653
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.